![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Ent. | LSE:HCEG | London | Ordinary Share | GB00B6030H73 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:9929R Healthcare Enterprise Group PLC 28 February 2007 THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA OR SOUTH AFRICA 28 February 2007 Healthcare Enterprise Group plc #1.6m cash placing Healthcare Enterprise Group plc (AIM: HCEG, "HCEG", or "the Group"), the healthcare products group, has raised approximately #1.632m (before expenses) by the placing of 27,200,000 new ordinary shares of 2.5p each ("the Placing Shares") at a placing price of 6 pence per share ("the Placing Price") principally with institutional investors. The Directors, management and consultants have agreed to subscribe in aggregate, #100,000 in the Placing. The net proceeds of the Placing, after costs estimated to be approximately #61,280, are expected to be approximately #1.571 million. The new funds raised will be used to support development of Ebiox, particularly for distribution and marketing arrangements. It will also be used to invest in IT support systems at the Group's Warrington operations (Crest Medical) and to provide additional working capital. Mark Tompkins, Group Chairman and Lyndon Gaborit, Executive Deputy Chairman and/ or their connected persons have agreed to subscribe for 250,000 Placing Shares at the Placing Price, respectively. This represents 0.16 per cent. of the issued share capital as enlarged by the Placing. Following completion of the Placing, Mark Tompkins and Lyndon Gaborit will own or be interested in 1,524,409 Ordinary Shares and 1,303,351 Ordinary Shares respectively representing approximately 0.50 per cent. and 0.43 per cent. of the Group's Enlarged Issued Share Capital respectively. Gron Ffoulkes-Davies, Chief Operating Officer of Crest Medical, has agreed to subscribe for 250,000 Placing Shares at the Placing Price, representing 0.08 per cent. of the Group's issued share capital as enlarged by the Placing. Following completion of the Placing, Gron Ffoulkes-Davies will be interested in 1,250,000 shares, representing approximately 0.41% of the Enlarged Issued Share Capital. HCEG consultants have further agreed to subscribe for 916,000 Placing Shares at the Placing Price, representing 0.30 per cent. of the issued share capital as enlarged by the Placing. The Group will apply for Admission of the Placing Shares to trading on AIM. Dealings in these shares are expected to commence on 6 March 2007. Enquiries: Healthcare Enterprise Group PLC 020 7351 7500 Mark Tompkins, Chairman Lyndon Gaborit, Executive Deputy Chairman Numis Securities Limited 020 7776 1500 David Poutney College Hill 020 7457 2020 Adrian Duffield / Corinna Dorward This information is provided by RNS The company news service from the London Stock Exchange END IOEUBOKRBVRUUAR
1 Year Healthcare Enterprise Chart |
1 Month Healthcare Enterprise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions